A Phase 1/2, First-in-human Study of DS-3939a in Patients with Advanced Solid Tumors: A New DXd ADC Targeting TA-MUC1.Noboru Yamamoto,Toshihiko Doi, Manish R. Patel,Ignacio Garrido-Laguna, Sutan Wu,Satoshi Nishioka,Keiko Nakajima, Benedito A. CarneiroJournal of Clinical Oncology（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
